Bruce Joseph Shook has sold STIM and made no open-market buys since Jun 2021

Bruce Joseph Shook is a medical device executive and corporate insider who serves as a Director of Neuronetics, Inc. (NASDAQ: STIM).( According to SEC-related insider ownership data, he has served on Neuronetics’ board as a director and has executed multiple equity transactions in the company, reflecting an ongoing governance and shareholder role.( Neuronetics appointed him to its Board of Directors in 2020, adding his operational and strategic experience in neuromodulation and vascular medical devices to the company’s leadership.(

Shook has more than 30 years of experience in the medical device industry, including venture financing for early-stage companies.( He previously co‑founded Neuronetics in 2003 and led it for about eleven years as President and Chief Executive Officer, overseeing all facets of the company’s operations and the development and commercialization of therapeutic neuromodulation products for psychiatric and neurologic diseases.( Before that, he co‑founded Neuron Therapeutics, focused on drug/device combination products for traumatic central nervous system disorders, and served as President of Abiomed (NASDAQ: ABMD), where he worked to bring the first ventricular assist device to the U.S. market and directed commercial operations.( Earlier in his career, he held roles in engineering, clinical research, and regulatory affairs at Cordis Corporation.( Shook holds a B.S. in Chemical Engineering from Penn State University, an advanced degree in Biomedical Engineering from Columbia University, and an MBA from the MIT Sloan School of Management, providing a technical and business foundation for his leadership in the med‑tech sector.(

Written by Perplexity from public sources.